Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-17-010005
Filing Date
2017-05-24
Accepted
2017-05-24 17:26:15
Documents
2
Period of Report
2017-05-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4387
2 EX-24 - POWER OF ATTORNEY EXHIBIT. pascoepoa.htm EX-24 9766
  Complete submission text file 0001437749-17-010005.txt   15620
Mailing Address C/O SOMAXON PHARMACEUTICALS, INC. 10935 VISTA SORRENTO PARKWAY, SUITE 250 SAN DIEGO CA 92130
Business Address
Pascoe Richard W (Reporting) CIK: 0001343266 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 17867627

Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations